Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06710392 · ClinicalTrials.gov registry record · NA
Efficacy of Two Enzyme Cocktails in Healthy Adults
A NA study, sponsored by The Archer-Daniels-Midland Company.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT06710392: Clinical Trial NA study, sponsored by The Archer-Daniels-Midland Company.
NCT06710392 is a NA study that was terminated before completion, run by The Archer-Daniels-Midland Company. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06710392, a NA study, was terminated before completion, sponsored by The Archer-Daniels-Midland Company.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The goal of this study is to determine the safety and efficacy of two enzyme cocktails in healthy adults with mild to moderate gastrointestinal discomfort. The main question aims to answer whether a 4-week administration of an enzyme cocktail can improve how the participant feels about their gut health. This is done by completing a weekly questionnaire, and the results are compared between the 4 weeks the participants are on a placebo and the 4 weeks the participants are on the enzyme cocktail. Participants will also provide a stool sample at the start and end of each treatment. Stool samples will collected and stored in case further microbiome analysis is warranted.
Primary Outcome
Change in GSRS-IBS total score from baseline to end of intervention. Each question is rated on a 7 point Likert scale with higher scores representing more troublesome symptoms. Questionnaire collected weekly from baseline through study completion at the end of week 12.
Interventions
- DIETARY_SUPPLEMENT Enzyme Cocktail A
- DIETARY_SUPPLEMENT Enzyme Cocktail B
- DIETARY_SUPPLEMENT Placebo A
- DIETARY_SUPPLEMENT Placebo B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-05-29 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Why NCT06710392 stopped before completion
NCT06710392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Enzyme Cocktail A is the first listed.
NCT06710392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06710392 about?
NCT06710392 is a clinical study titled "Efficacy of Two Enzyme Cocktails in Healthy Adults". The goal of this study is to determine the safety and efficacy of two enzyme cocktails in healthy adults with mild to moderate gastrointestinal discomfort. The main question aims to answer whether a 4-week administration of an enzyme cocktail can improve how the participant feels about their gut hea...
What is the current status of trial NCT06710392?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2025-05-29. Estimated completion is 2026-02-28.
What interventions are being tested in trial NCT06710392?
The interventions under investigation include: Enzyme Cocktail A (DIETARY_SUPPLEMENT), Enzyme Cocktail B (DIETARY_SUPPLEMENT), Placebo A (DIETARY_SUPPLEMENT), Placebo B (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06710392?
This trial is sponsored by The Archer-Daniels-Midland Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06710392's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI